葡萄膜炎

Deschenes J, Murray PI, Rao NA, et al; International Uveitis Study Group. International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm. 2008;16:1-2.

• 摘要

Jabs DA, Nussenblatt RD, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509-516.

• 摘要

Rothova A, van Veenedaal WG, Linssen A, et al. Clinical features of acute anterior uveitis. Am J Ophthalmol. 1987;103:137-145.

• 摘要

Kempen JH, Altaweel MM, Holbrook JT, et al; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology. 2011;118:1916-1926. [Erratum in: Ophthalmology. 2012;119:212.]

• 全文
• 摘要

1.  Deschenes J, Murray PI, Rao NA, et al; International Uveitis Study Group. International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm. 2008;16:1-2.

• 摘要

2.  Jabs DA, Nussenblatt RD, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509-516.

• 摘要

3.  American Optometric Association. Optometric clinical practice guideline: care of the patient with anterior uveitis. 1999. http://www.aoa.org/ (last accessed 20 July 2017).

• 全文

4.  Silverstein A. Changing trends in the etiologic diagnosis of uveitis. Doc Ophthalmol. 1997;94:25-37.

• 摘要

5.  Baarsma GS. The epidemiology and genetics of endogenous uveitis: a review. Curr Eye Res. 1992;11 suppl:1-9.

• 摘要

6.  Vadot E. Epidemiology of intermediate uveitis: a prospective study in Savoy. Dev Ophthalmol. 1992;23:33-34.

• 摘要

7.  Gritz DG, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004;111:491-500.

• 摘要

8.  Thean LH, Thompson J, Rosenthal AR. A uveitis register at the Leicester Royal Infirmary. Ophthalmic Epidemiol. 1996;3:151-158.

• 摘要

9.  Barisani-Asenbauer T, Maca SM, Mejdoubi L, et al. Uveitis - a rare disease often associated with systemic diseases and infections - a systematic review of 2619 patients. Orphanet J Rare Dis. 2012;7:57.

• 全文
• 摘要

10.  Paivonsalo-Hietanen T, Tuominen J, Vaahtoranta-Lehtonen H, et al. Incidence and prevalence of different uveitis entities in Finland. Acta Ophthalmol Scand. 1997;75:76-81.

• 摘要

11.  Biswas J, Narain S, Das D, et al. Pattern of uveitis in a referral uveitis clinic in India. Int Ophthalmol. 1996-1997;20:223-228.

• 摘要

12.  Merrill PT, Kim J, Cox TA, et al. Uveitis in the southeastern United States. Curr Eye Res. 1997;16:865-874.

• 摘要

13.  Wakefield D, Dunlop I, McClusky PJ, et al. Uveitis: aetiology and disease associations in an Australian Population. Aus NZ J Ophthalmol. 1986;14:181-187.

• 摘要

14.  Rothova A, van Veenedaal WG, Linssen A, et al. Clinical features of acute anterior uveitis. Am J Ophthalmol. 1987;103:137-145.

• 摘要

15.  Murray CJ, Ortblad KF, Guinovart C, el al; GBD Study group. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:1005-1070.

• 全文
• 摘要

16.  Cincinnati Children's Hospital Medical Center. Best Evidence Statement (BESt 011). Screening for uveitis in children with juvenile idiopathic arthritis (JIA). June 2012. http://www.cincinnatichildrens.org/ (last accessed 20 July 2017).

• 全文

17.  Colucciello M. Ocular Lyme borreliosis. N Engl J Med. 2001;345:1350-1351.

• 摘要

18.  Margolis R, Brasil OF, Lowder CY, et al. Vitrectomy for the diagnosis and management of uveitis of unknown cause. Ophthalmology. 2007;114:1893-1897.

• 摘要

19.  Smith JR, Rosenbaum JT. Management of uveitis: a rheumatologic perspective. Arthritis Rheum. 2002;46;309-318.

• 摘要

20.  Gui W, Dombrow M, Marcus I, et al. Quality of life in patients with noninfectious uveitis treated with or without systemic anti-inflammatory therapy. Ocul Immunol Inflamm. 2014;27:1-9.

• 摘要

21.  Lemley C, Han DP. Endophthalmitis: a review of current evaluation and management. Retina. 2007;27:662-680.

• 摘要

22.  Jaffe GJ, Martin D, Callanan D, et al. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. Ophthalmology. 2006;113:1020-1027.

• 摘要

23.  Jaffe GJ, Dick AD, Brézin AP, et al. Adalimumab in patients with active noninfectious uveitis. N Engl J Med. 2016;375:932-943.

• 全文
• 摘要

24.  Nguyen QD, Merrill PT, Jaffe GJ, et al. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet. 2016;388:1183-1192.

• 摘要

25.  Durrani K, Zakka FR, Ahmed M, et al. Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease. Surv Ophthalmol. 2011;56:474-510.

• 摘要

26.  Kempen JH, Altaweel MM, Holbrook JT, et al; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology. 2011;118:1916-1926. [Erratum in: Ophthalmology. 2012;119:212.]

• 全文
• 摘要

27.  Brady CJ, Villanti AC, Law HA, et al. Corticosteroid implants for chronic non-infectious uveitis. Cochrane Database Syst Rev. 2016;(2):CD010469.

• 全文
• 摘要

28.  Kempen JH, Altaweel MM, Holbrook JT, et al; Writing Committee for the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group. Association between long-lasting intravitreous fluocinolone acetonide implant vs systemic anti-inflammatory therapy and visual acuity at 7 years among patients with intermediate, posterior, or panuveitis. JAMA. 2017;317:1993-2005.

• 摘要

29.  Maya JR, Sadiq MA, Zapata LJ, et al. Emerging therapies for noninfectious uveitis: what may be coming to the clinics. J Ophthalmol. 2014;2014:310329.

• 全文
• 摘要

30.  Rothova A, Suttorp-van Schulten MS, Frits Treffers W, et al. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80:332-336.

• 全文
• 摘要